Has the GPhC decided to replace OSPAP?

Not yet. The consultation on draft standards ran from 28 April to 21 July 2026 and has closed, but as of late August 2026 the GPhC has not published its response or approved the new standards. The proposals remain draft, and no implementation date has been confirmed beyond the consultation document's statement that the earliest new programmes could run is the 2028/29 academic year.

If I start OSPAP in 2027, will I be able to finish?

Yes. The consultation document states that OSPAP providers may accept applications for existing programmes in 2026 and 2027, that students in those groups will be eligible to apply for the foundation training year, and that NHS England will offer foundation training for groups up to and including those joining the 2028 foundation training year. The route through to registration is accounted for.

Is the new one-year route better than OSPAP?

It would be shorter and would embed independent prescribing, which OSPAP does not — OSPAP graduates register without the prescribing annotation and add it through a separate programme afterwards. But the new route has not been approved, priced, accredited or scheduled, and the requirement to have two years of post-registration experience before starting a prescribing programme was removed in October 2022, so the gap can be closed relatively quickly while employed.

What is the risk of waiting until 2028 or later?

The main one is your GPhC eligibility expiring. You must start an OSPAP within two years of being notified you are eligible, extendable by up to two further years, after which you reapply and pay again. Sitting out both the 2026 and 2027 intakes to wait for a programme starting in 2028/29 at the earliest can mean reapplying from scratch. You also forgo a paid foundation training year — NHS Band 5 starts at £32,073 in England from April 2026.

What should I do right now?

Apply to the GPhC for eligibility, whichever way you are leaning. None of the four universities is accepting September 2027 applications yet, but GPhC eligibility is open, takes months, and is required before any provider will consider you. Starting it costs you no optionality and makes you ready when application windows open.

All articles

Study in UK

Apply for OSPAP in 2027, or Wait for the New One-Year Route?

Amir Shah 29 August 2026 OSPAP, OSPAP 2027, GPhC

Since the GPhC published its proposals in April 2026, this has become the most common question we get from internationally qualified pharmacists: should I apply for OSPAP in 2027, or wait for the new one-year integrated route?

It is a reasonable question. The proposed replacement is shorter, and it would build independent prescribing into the qualification rather than leaving graduates to add it afterwards. On paper, waiting looks like the smarter move. In practice, for almost everyone we advise, it is not — and the reasons are specific rather than a general "don't delay."

Here is what is actually settled, what is not, and how to weigh the two against your own circumstances.

What is confirmed

The GPhC consulted between 28 April and 21 July 2026 on draft standards that would replace the current two-year route — a one-year OSPAP diploma followed by a one-year foundation training year and the registration assessment — with a single integrated one-year programme that includes prescribing training.

That consultation has closed. As of late August 2026, the GPhC has not published its response or approved anything. The draft standards remain draft.

Three things in the consultation document are firm enough to plan around:

The earliest any new programme could run is the 2028/29 academic year. Not 2027. Not 2028 entry in the sense most applicants mean it.
OSPAP providers may accept applications for existing programmes in 2026 and 2027, and students in those groups will be eligible to apply for the foundation training year.
NHS England will continue offering foundation training for groups up to and including those joining the 2028 foundation training year.

That third point is the one that should settle most nerves. The single biggest risk in starting a route that is being replaced is finishing the taught stage and finding the next stage has been withdrawn. That risk has been explicitly addressed in writing. We go through the proposals themselves in our guide to whether OSPAP is being replaced.

What is not confirmed

Almost everything else, and this is where waiting gets expensive:

Whether the standards will be approved as drafted. Consultations change proposals. The response has not been published.
When the first new programmes would actually recruit. "2028/29 at the earliest" is a floor, not a date. Universities need to design programmes, have them accredited, and open admissions — each of which can slip.
Which universities would run it, and at what price. The consultation notes fees would be set by providers. There is no figure.
How many places there would be. Around 400 OSPAP students enrol each year across the four accredited providers today. A new route's capacity is unknown.

Waiting is therefore not a choice between a two-year route now and a one-year route in 2028. It is a choice between a route that exists and one that has not been approved, priced, accredited or scheduled.

The real cost of waiting

Your GPhC eligibility has a clock on it

This is the part applicants most often miss. Once the GPhC notifies you that you are eligible to complete an OSPAP, you must begin the course within two years. You can request an extension of up to a further two years, but four years after your initial application your eligibility lapses entirely and you reapply and pay again.

If you already hold eligibility and you sit out both the 2026 and 2027 intakes waiting for a programme that starts in 2028/29 at the earliest, you may well be reapplying from scratch. Check your notification date before you decide anything.

You are giving up a paid year, not just a year

The foundation training year is employment. In England, trainee pharmacists sit at NHS Band 5, which starts at £32,073 from 1 April 2026; in Scotland the rate is £34,544. Someone who starts OSPAP in September 2027 is earning that salary during 2028/29 — the same year the earliest new-route students would be starting their programme and paying tuition for the privilege.

Compare the two positions in 2029. The 2027 OSPAP applicant is registered or nearly registered and earning. The waiter is midway through an unapproved programme, one year in, with fees paid.

Rules change while you wait, and rarely in your favour

The last twelve months alone brought a Student visa fee rise to £558 in April 2026, maintenance requirements of £1,529 per month in London and £1,171 outside it, a confirmed international student levy of £925 per international student per year from August 2028, and a Graduate Route reduction from two years to 18 months for taught postgraduates applying on or after 1 January 2027. None of those moved in applicants' favour. Our guide to current UK student visa requirements has the detail.

The honest case for waiting

There is one, and it is worth stating fairly rather than dismissing.

The new route would embed independent prescribing. Under the current system, OSPAP graduates do not get the prescribing annotation on registration — since summer 2026, UK graduates trained to the GPhC's 2021 standards do, but OSPAP graduates train against interim learning outcomes that exclude it. You register, then complete a separate GPhC-accredited prescribing programme afterwards.

So a new-route graduate would arrive on the register with something an OSPAP graduate has to go back for. That is a genuine difference, and if you are early in your career and not under financial pressure, it carries weight.

But weigh it properly. The requirement to have two years of post-registration experience before starting a prescribing programme was removed in October 2022. You can begin one relatively soon after registering, while employed and earning, rather than waiting years. The gap between the two routes is a course you take afterwards — not a permanent ceiling. We set out how to close it in what prescriber status from 2026 means for OSPAP graduates.

Who should apply for 2027, and who might reasonably wait

Apply for 2027 if you already hold GPhC eligibility, or you are ready to start the eligibility process now; you need to be earning in the UK within roughly two to three years; you are supporting family or servicing loans; or you are simply in a position to move. This is the large majority of people we speak to.

Waiting may be defensible if you are years away from being able to relocate anyway, you have no live GPhC eligibility to lose, and you are relaxed about a start date that could move again. Even then, we would suggest tracking the GPhC's response when it is published rather than assuming a timeline.

What we would not advise is the middle position: holding live eligibility, being ready to move, and waiting anyway. That combination burns the clock on something you have already paid for, in exchange for a programme nobody can yet give you a date for.

What to do this autumn either way

The useful thing about this cycle is that the slow step is available even though the fast one is not. None of the four universities is accepting September 2027 applications yet — Brighton says so explicitly on its course page — but GPhC eligibility is open, takes months, and is required before any of them will consider you.

So the answer for nearly everyone is the same regardless of which way you are leaning: start the GPhC eligibility application now. It is required for the current route, it is the assessment of your overseas qualification that any future route will also need in some form, and it costs you nothing in optionality. If you decide to wait after all, you have lost little. If you decide to apply, you are ready when windows open.

Our step-by-step guide to applying for OSPAP in 2027 sets out the full sequence, and the eligibility requirements guide covers what the GPhC assesses. If you are still deciding between providers, our fee comparison covers all four.